tiprankstipranks
Pediatrix Medical Group, Inc. (MX:MD)
NYSE:MD
Mexico Market
MD
Pediatrix Medical Group
RESEARCH TOOLSreports

Pediatrix Medical Group (MD) Ratios

0 Followers

Pediatrix Medical Group Ratios

MX:MD's free cash flow for Q2 2026 was $0.27. For the 2026 fiscal year, MX:MD's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.32 1.66 1.47 1.24 1.00
Quick Ratio
 1.32 1.66 1.47 1.24 1.00
Cash Ratio
 0.58 0.82 0.53 0.19 0.02
Solvency Ratio
 0.16 0.14 -0.05 -0.02 0.07
Operating Cash Flow Ratio
 0.49 0.59 0.48 0.35 0.39
Short-Term Operating Cash Flow Coverage
 1.33 7.06 11.02 10.99 13.36
Net Current Asset Value
$ -589.22M$ -617.33M$ -748.15M$ -887.29M$ -1.03B
Leverage Ratios
Debt-to-Assets Ratio
 0.29 0.29 0.31 0.32 0.31
Debt-to-Equity Ratio
 0.70 0.76 0.87 0.83 0.80
Debt-to-Capital Ratio
 0.41 0.43 0.46 0.45 0.45
Long-Term Debt-to-Capital Ratio
 0.31 0.41 0.44 0.42 0.41
Financial Leverage Ratio
 2.42 2.59 2.81 2.61 2.63
Debt Service Coverage Ratio
 1.01 3.00 -0.44 0.33 2.64
Interest Coverage Ratio
 8.01 6.43 -1.69 0.17 4.35
Debt to Market Cap
 0.27 0.35 0.56 0.80 0.52
Interest Debt Per Share
 8.16 8.17 8.44 8.85 9.12
Net Debt to EBITDA
 1.24 1.04 -15.24 21.03 4.51
Profitability Margins
Gross Profit Margin
25.95%24.66%22.57%21.13%23.68%
EBIT Margin
12.51%13.19%-3.01%-0.32%6.14%
EBITDA Margin
13.69%14.33%-1.41%1.50%7.95%
Operating Profit Margin
11.60%12.07%-3.41%0.37%8.76%
Pretax Profit Margin
11.60%11.31%-5.03%-2.42%4.13%
Net Profit Margin
8.96%8.64%-4.92%-3.03%3.36%
Continuous Operations Profit Margin
8.96%8.64%-4.92%-3.03%3.17%
Net Income Per EBT
77.27%76.42%97.76%124.92%81.52%
EBT Per EBIT
100.00%93.66%147.48%-660.55%47.12%
Return on Assets (ROA)
8.21%7.36%-4.60%-2.72%2.83%
Return on Equity (ROE)
19.89%19.10%-12.95%-7.11%7.44%
Return on Capital Employed (ROCE)
13.89%12.93%-4.00%0.40%8.99%
Return on Invested Capital (ROIC)
9.57%9.67%-3.83%0.39%6.78%
Return on Tangible Assets
20.62%17.07%-11.03%-7.42%8.32%
Earnings Yield
8.21%9.07%-9.06%-7.73%5.38%
Efficiency Ratios
Receivables Turnover
 8.16 7.90 7.38 7.13 6.64
Payables Turnover
 4.79 38.74 33.57 45.48 47.24
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 26.40 26.04 25.66 13.67 14.06
Asset Turnover
 0.92 0.85 0.94 0.90 0.84
Working Capital Turnover Ratio
 12.88 7.50 13.42 41.77 9.52
Cash Conversion Cycle
 -31.55 36.79 38.56 43.19 47.21
Days of Sales Outstanding
 44.72 46.21 49.43 51.21 54.93
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 76.27 9.42 10.87 8.03 7.73
Operating Cycle
 44.72 46.21 49.43 51.21 54.93
Cash Flow Ratios
Operating Cash Flow Per Share
 3.11 3.18 2.48 1.63 2.01
Free Cash Flow Per Share
 2.88 2.96 2.21 1.24 1.65
CapEx Per Share
 0.23 0.22 0.26 0.40 0.36
Free Cash Flow to Operating Cash Flow
 0.93 0.93 0.89 0.76 0.82
Dividend Paid and CapEx Coverage Ratio
 13.54 14.69 9.38 4.12 5.62
Capital Expenditure Coverage Ratio
 13.54 14.69 9.38 4.12 5.62
Operating Cash Flow Coverage Ratio
 0.40 0.41 0.31 0.20 0.23
Operating Cash Flow to Sales Ratio
 0.13 0.14 0.10 0.07 0.08
Free Cash Flow Yield
10.40%13.85%16.88%13.31%11.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.70 11.03 -11.03 -12.93 18.58
Price-to-Sales (P/S) Ratio
 1.13 0.95 0.54 0.39 0.63
Price-to-Book (P/B) Ratio
 2.42 2.11 1.43 0.92 1.38
Price-to-Free Cash Flow (P/FCF) Ratio
 9.61 7.22 5.92 7.51 8.98
Price-to-Operating Cash Flow Ratio
 8.61 6.73 5.29 5.69 7.38
Price-to-Earnings Growth (PEG) Ratio
 0.19 -0.04 -0.17 0.07 -0.39
Price-to-Fair Value
 2.42 2.11 1.43 0.92 1.38
Enterprise Value Multiple
 9.48 7.69 -53.77 47.17 12.38
Enterprise Value
 2.53B 2.11B 1.53B 1.41B 1.94B
EV to EBITDA
 9.48 7.69 -53.77 47.17 12.38
EV to Sales
 1.30 1.10 0.76 0.71 0.98
EV to Free Cash Flow
 11.06 8.35 8.27 13.56 14.14
EV to Operating Cash Flow
 10.24 7.78 7.39 10.27 11.62
Tangible Book Value Per Share
 -5.06 -4.83 -5.87 -6.62 -7.94
Shareholders’ Equity Per Share
 11.09 10.15 9.18 10.11 10.75
Tax and Other Ratios
Effective Tax Rate
 0.23 0.24 0.02 -0.25 0.23
Revenue Per Share
 24.55 22.45 24.16 23.74 23.77
Net Income Per Share
 2.20 1.94 -1.19 -0.72 0.80
Tax Burden
 0.77 0.76 0.98 1.25 0.82
Interest Burden
 0.93 0.86 1.67 7.70 0.67
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.13 0.13 0.12 0.11 0.12
Stock-Based Compensation to Revenue
 0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.41 1.64 -2.09 -2.27 2.67
Currency in USD